Skip to main content
. 2015 Jun 17;2(1):e000262. doi: 10.1136/openhrt-2015-000262

Table 1.

Health benefits of capsaicin administration suggested by preclinical and clinical research

Condition benefited Likely mechanisms of action
Atherosclerosis26 29 30 Improved endothelial function, including eNOS activation/induction; induction of LXRalpha in foam cells, promoting cholesterol export
Diabetic vasculopathy39 Induction of UCP2 and eNOS in endothelium
Stroke28 Improved endothelial function, including eNOS activation/induction
Angina31 Improved endothelium-dependent vasodilation of coronary arteries
Hypertension27 32 33 Activation/induction of eNOS; decreased renal sodium retention
Metabolic syndrome54–58 Decreased adipose inflammation—reflecting PPARgamma induction
Cardiac hypertrophy41 Induction of PPARdelta
Fatty liver39 52 Induction of UCP2 in hepatocytes; decreased adipose inflammation Increased GLP-1 secretion
Obesity56 57 61 62 66 Sympathetic activation of brown fat thermogenesis Improved appetite control—vagal signal to appetite centers, ↑ GLP-1; increased adipocyte capacity for lipolysis
Gastric ulceration68–70 Decreased acid secretion; increased alkali; increased gastric blood flow

eNOS, endothelial nitric oxide synthase; GLP-1, glucagon-like peptide-1; UCP2, uncoupling protein 2